News @ a glance

February 2006
CMAJ: Canadian Medical Association Journal;2/28/2006, Vol. 174 Issue 5, p608
Academic Journal
The article presents news briefs concerning medical care. The QuantiFERON-TB Gold blood test for tuberculosis has been approved for use by the U.S. Centers for Disease Control and Prevention. Health Canada has decided to remove valdecoxib, a COX-2 selective inhibitor for arthritis and pain, from the market due to a potential increased risk of cardiovascular events. The World Health Organization requested several drug companies to stop selling artemisinin for treating malaria.


Related Articles

  • BCG vaccine.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p10 

    The article presents a case study of a 7-month-old baby girl diagnosed with systemic BCG infection developed while receiving BCG vaccination.

  • Ciclosporin.  // Reactions Weekly;Feb2015, Vol. 1538 Issue 1, p68 

    The article presents a case study of a 27-year-old man who was diagnosed with cerebral tuberculosis, hepatocellular injury secondary to hepatitis B virus reactivation with subsequent fatal liver failure after receiving ciclosporin.

  • Immunosuppressants.  // Reactions Weekly;Apr2015, Vol. 1548 Issue 1, p136 

    The article presents a case study of a 60-year-old woman who developed tuberculosis during the administration of immunosuppressants antithymocyte globulin, methylprednisolone, mycophenolic acid and tacrolimus.

  • Infliximab.  // Reactions Weekly;Aug2015, Vol. 1564 Issue 1, p113 

    The article presents a case study of a patient who was diagnosed with latent tuberculosis following treatment with infliximab for psoriasis.

  • Prednisone.  // Reactions Weekly;Nov2015, Vol. 1577 Issue 1, p211 

    The article presents case studies of patients who developed pulmonary tuberculosis and lung abscess during the administration of allergic drug prednisone.

  • MANAGED CARE PERSPECTIVES: 2010 UPDATE. Rich, Sheldon J. // University of Tennessee Advanced Studies in Pharmacy;2010, Vol. 7 Issue 3, p75 

    Multiple sclerosis (MS) is a chronic disease that requires ongoing drug therapy to delay disability progression. This article reviews various patientspecific factors (ie, lifestyle, financial status, and tolerance to adverse effects) that should be considered when individualizing drug therapy to...

  • Elderly patients may benefit from flu vaccine dosage change.  // Healthcare Traveler;Sep2006, Vol. 14 Issue 3, p37 

    The article deals with a study that discovered the advantage of giving higher-than-normal doses of the influenza vaccine to elderly patients. Different doses of the vaccine were given to 200 older adults. Side effects were observed in the subjects. Antibody levels in the patients were compared...

  • Dear Healthcare letter for etravirine.  // AIDS Alert;Oct2009, Vol. 24 Issue 10, p118 

    The article offers information on the "Dear Healthcare Professional" letter, issued by Tibotec Therapeutics, and the U.S. Food and Drug Administration to relay updated prescribing information on etravirine's safety update regarding severe skin and hypersensitivity reactions.

  • Monitoring adverse reactions to drugs. Dollery, C.T.; Rawlins, M.D. // British Medical Journal;1/8/1977, Vol. 1 Issue 6053, p96 

    Focuses on monitoring the adverse reactions of drugs in Great Britain. Use of a voluntary system of spontaneous reporting; Deficiencies of the yellow-card system; Concept of monitored release.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics